(Circulation. 1996;93:1509-1514.)
© 1996 American Heart Association, Inc.
Articles |
From the Cardiology Division, Department of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital.
Correspondence to Dr J.E. Sanderson, Department of Medicine, The Chinese University of Hong Kong, 9/F Clinical Sciences Bldg, Prince of Wales Hospital, Shatin, NT, Hong Kong. E-mail jesanderson@cuhk.edu.hk.
| Abstract |
|---|
|
|
|---|
Methods and Results Transtricuspid and pulmonary artery flow were assessed by two-dimensional Doppler echocardiography at maximum inspiration and expiration in 185 subjects: 114 symptomatic HF patients (ejection fraction <0.5), 31 PHT patients (pulmonary artery systolic pressure >40 mm Hg), and 40 normal subjects. A subset was matched for age and heart rate. The results showed a high prevalence of RV diastolic abnormalities: HF patients had lower tricuspid E-A ratios, lower peak E-wave velocity, and prolonged RV isovolumic relaxation time (all P<.0001). Tricuspid E-wave deceleration time was significantly shorter only in those who had an LV restrictive filling pattern. The PHT group had similar findings. Compared with a normal range, more than half of the patients had lower tricuspid E-A ratios (HF, 55%; PHT, 69%), and 61% of HF and 58% of PHT patients had a prolonged RV isovolumic relaxation time. In the PHT group, RV diastolic parameters (E-wave deceleration time, E-A ratio, and isovolumic relaxation time) correlated significantly with pulmonary artery systolic pressure (P<.05). In the HF group, however, only tricuspid E-wave deceleration time correlated significantly with pulmonary artery systolic pressure, and HF patients with normal pulmonary artery systolic pressures had significantly lower tricuspid E-A ratios and prolonged RV isovolumic relaxation times compared with normal subjects. A close correlation existed between individual RV and LV diastolic parameters, suggesting that LV diastolic dysfunction may directly affect RV function, but there was no relation between LV size or systolic function and RV diastolic dysfunction.
Conclusions RV diastolic function is frequently abnormal in HF patients, and this is not related to elevated pulmonary artery systolic pressure alone, although high pulmonary artery pressure by itself also is associated with impaired RV diastolic function. Assessment of the role of right ventricular diastolic function in determining the symptoms and prognosis of heart failure is warranted.
Key Words: ventricles diastole heart failure
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
HF Group
One hundred fourteen consecutive patients with
symptomatic HF (mean age, 62.7±1.23 years; 66% men) were
studied. The cause of HF was idiopathic dilated
cardiomyopathy in 42 patients (36.8%),
ischemic heart disease in 59 (51.8%), hypertensive heart
disease in 8 (7.0%), and aortic valve disease (aortic
regurgitation in 3 and mixed stenosis and
regurgitation in 2) with severe LV dysfunction in 5
(4.4%). Idiopathic dilated cardiomyopathy was
diagnosed if there was no clear cause and ejection fraction was <50%.
Coronary angiography and endomyocardial
biopsy were not considered mandatory and were performed in 60% and
43% of patients, respectively. Patients with ischemic heart
disease had either a history of myocardial infarction or severe
coronary artery disease on arteriogram, ejection fractions
<50%, and LV enlargement on the echocardiogram
(end-diastolic dimension >5.6 cm on long-axis view
by M-mode echocardiography).
PHT Group
Thirty-one consecutive patients (mean age, 55±3.35 years;
48% men) with PHT were studied. PASP was >40 mm Hg by
continuous-wave Doppler echocardiography
with normal LV systolic function (LV ejection fraction >55%).
The cause of PHT was chronic obstructive airways disease in 19 patients
(61.3%), valvular heart disease in 6 (aortic
regurgitation in 3, mitral
regurgitation in 3; 19.3%), congenital heart disease
in 3 (atrial septal defects in 2, ventricular septal defect
in 1; 9.7%), systemic lupus erythematosus in 2
(6.5%), and idiopathic PHT in 1 (3.2%).
Normal Control Subjects
Forty normal subjects (mean age, 50.2±2.66 years; 45% men)
free of heart or lung disease were selected as control subjects.
Doppler Echocardiographic
Examination
Two-dimensional echocardiography with
continuous- and pulse-wave Doppler studies was performed.
Standard M-mode measurements of LV systolic function were
performed. Pulse-wave Doppler
echocardiography was performed for both the left
and right ventricles. In the left ventricle, mitral in-flow
velocities in the apical four-chamber view with the sampling window
placed at the mitral annulus (to standardize measurements) were
recorded. Diastolic parameters were
measured for at least three beats. These parameters
included peak early mitral valve filling velocity (E wave), peak atrial
filling velocity (A wave), E-A ratio, and DT. IVRT was measured by
moving the sampling window to a position between the anterior mitral
leaflet and LV outflow tract. The LV diastolic mitral flow
pattern was divided into a normal pattern, ARP, and RFP as previously
described. ARP was characterized by prolonged DT (>240 ms), reversed
E-A ratio, and prolonged IVRT (>100 ms); RFP was characterized by a
short DT (<140 ms), large E-A ratio (>2), and short IVRT (<70
ms).2 4
RV diastolic function was assessed with the parasternal short-axis view at the level of the tricuspid valve. The sampling window was placed at the tricuspid annulus. RV diastolic parameters corresponding to those of the left ventricle were measured. The RV-IVRT was defined as the time interval between the closure of the pulmonary valve and opening of the tricuspid valve. This was estimated by subtracting the time interval between the peak of the R wave on the ECG and the onset of the tricuspid valve opening from the interval between the peak of the R wave and the end of the pulmonary systolic flow profile. Because the RV diastolic filling is affected by respiration, measurement of beats was timed with respiration. At least three beats from the end inspiration and three beats from the end expiration were recorded, and their values were averaged. PASP was estimated by continuous-wave Doppler echocardiograms recorded in the apical four-chamber view as the peak systolic pressure gradient across the tricuspid valve (peak regurgitation velocity) plus the estimated right atrial pressure (10 mm Hg).
Statistical Analysis
The echocardiographic data between different
diagnostic groups and subgroups and between ARP and RFP
were compared by use of an unpaired t test or ANOVA as
appropriate. The correlation of PASP with RV diastolic
parameters was examined by multiple linear regression. The
relationship between LV and RV diastolic
parameters was examined by correlation analysis.
All data are expressed as mean±SEM. A value of P<.05 was
considered statistically significant.
| Results |
|---|
|
|
|---|
|
|
Heart rate was significantly higher in the PHT (79.8±3.0 bpm) and HF (82.1±1.6 bpm) groups than in normal control subjects (70.0±1.7 bpm, both P<.01). However, when groups of normal subjects and HF patients (28 from each group) matched for heart rate (mean, 70.5±1.9 and 70.5±1.9 bpm, respectively; P=.996) and age (mean, 54.0±3.1 and 56.2±2.8 years, respectively; P=.60) were compared, the HF patients still had significantly lower tricuspid peak E-wave velocity (44.1±1.8 versus 52.2±1.9 cm/s, P=.003), lower tricuspid E-A ratio (1.06±0.07 versus 1.25±0.04, P=.022), and longer RV-IVRT (99.7±7.4 versus 55.5±4.1 ms, P<.0001), but no significant difference was seen in PASP (30.4±2.6 versus 27.7±1.6 mm Hg, P=.39). In a similar comparison of patients with PHT and normal control subjects (15 in each group) matched for heart rate (mean, 71.9±2.6 and 73.0±2.9 bpm, respectively; P=.77) and age (mean, 50.0±4.7 and 55.4±4.7 years, respectively; P=.43), tricuspid peak E-wave velocity and E-A ratio were lower in the PHT group (E-wave velocity, 43.2±3.6 versus 52.8±2.5 cm/s, P=.035; E-A ratio, 0.85±0.04 versus 1.18±0.08, P=.001), and RV-IVRT was longer (90.1±10.7 versus 53.7±5.0 ms, P=.003). DT was not significantly different.
Correlation of RV Diastolic Parameters With
PASP by Multiple Linear Regression
When the individual RV diastolic
parameters of all patients were correlated with PASP by
multiple regression (Table 3
), there was a significant
negative correlation of PASP with DT (r=- .453,
P<.0001) and tricuspid E-A ratio (r=-.341,
P<.0001; Figs 1
and 2
).
However, among the HF patients, only the tricuspid DT correlated
significantly with PASP (r=-.476,
P<.0001). On the other hand, in the PHT group, PASP
correlated with not only DT (r=- 0.593,
P=.0082) but also tricuspid E-A ratio
(r=-.628, P=.0023) and RV-IVRT
(r=.123, P=.0360).
|
|
|
HF Group: Normal Versus High PASPs
Patients with HF who had normal PASP also had significant
differences in most RV diastolic parameters
compared with normal control subjects (Table 4
). In
addition, there were differences in the RV diastolic
parameters between HF patients with normal and high PASPs
(Table 4
). In particular, the DT in HF patients with normal PASP was
similar to that of normal subjects but was significantly reduced in HF
patients with high PASP. There also was a significantly greater
prolongation of the RV-IVRT in HF patients with high PASP, indicating
that the elevated PASP per se affects predominantly the DT and the
RV-IVRT.
|
Dilated Cardiomyopathy Versus Ischemic
Heart Disease With Anterior Myocardial Infarction
Patients
Forty patients with idiopathic dilated
cardiomyopathies were compared with 41 patients
with HF caused by a previous large anterior myocardial infarction
(Table 5
). There was no difference in either RV or LV
diastolic parameters in these two groups.
|
Relation of RV Diastolic Function to LV
Diastolic Function, LV Size, and LV Systolic
Function in the HF Group
There was a significant correlation between individual RV and LV
diastolic parameters: E-wave velocity,
r=.216, P=.003; A-wave velocity,
r=.289, P<.001; E-A ratio, r=.214,
P=.007; DT, r=.519, P<.001; and IVRT,
r=.230, P=.004. When the HF patients were
classified according to the different patterns of LV
diastolic dysfunction, 34 had ARP, 69 had RFP, and 11 had a
normal pattern (possibly pseudonormal but pulmonary vein flow
velocities were not measured). Compared with control subjects, there
were significant differences in most of the RV diastolic
parameters in both LV-ARP and LV-RFP subgroups (Table 1
).
When the patients with normal PASPs in these two groups were selected
for comparison, differences were still apparent in tricuspid peak
A-wave velocity (LV-ARP versus LV-RFP, 45.11±1.71 versus 39.77±1.56
cm/s, P=.025), tricuspid E-A ratio (0.95±0.05 versus
1.14±0.06, P=.012), and DT (227.98±11.11 versus
165.56±7.17 ms, P<.0001; Table 6
). In
addition, to ascertain the effect of LV size on RV
diastolic function, multiple regression analysis
was done between LV end-diastolic dimension (the
dependent variable) and RV-IVRT, tricuspid peak A-wave velocity,
peak E-wave velocity, E-A ratio, and DT; there were no significant
relations (P=.53, P=.59, P=.55,
P=.79, and P=.86, respectively). Similarly, LV
end-diastolic dimension was similar (P=.98)
in those patients with normal (6.4±0.23 cm) or abnormal (6.4±0.11) RV
diastolic function. Similarly, there was no significant
association between RV diastolic parameters
(either individual values or patterns) and LV fractional shortening or
LV ejection fraction. Thus, RV diastolic dysfunction does
not correlate with either LV size or LV systolic function.
|
| Discussion |
|---|
|
|
|---|
Few studies have been done on RV function in HF, and its role has probably been underestimated. Polak et al13 found that patients with an RV ejection fraction <35% at rest had a significantly higher 2-year mortality. Recently, Di Salvo et al14 in the largest study to date concluded that RV ejection fraction >0.35 was a more potent predictor of survival in advanced HF than VO2. In that study, LV ejection fraction at rest was not predictive of overall or event-free survival in any univariate or multivariate analysis.14 However, the only study in the literature that has assessed RV diastolic function in HF patients is a report by Riggs15 of 6 children with dilated cardiomyopathy, all of whom had abnormal RV filling. In our study, we confirmed that RV diastolic dysfunction is common, with prolonged IVRT occurring in nearly 60% of patients and reversed tricuspid E-A ratio occurring in 55% of patients with HF. Because LV diastolic function, particularly the restrictive filling pattern, has been shown to provide important prognostic information,1 2 3 it is possible that RV diastolic dysfunction is equally important. Follow-up of this group of patients will determine whether additional information provided by assessment of RV diastolic function will increase the accuracy of predictions of outcome and prognosis.
We have confirmed that whatever the cause, RV diastolic function is impaired in PHT patients. In a group of patients with chronic obstructive lung disease, Marangoni et al16 similarly found a good correlation between PASP and indexes of diastolic function. Obviously, one mechanism for impaired RV diastolic function in HF patients is PHT secondary to increased left atrial pressure. Both the tricuspid E-A ratio and DT correlated significantly with PASP for all subjects. In the present study, the HF and PHT groups had similar abnormalities of RV diastolic function. The DT tended to be shorter in the PHT group (P=NS), and this was the only parameter that correlated with PASP in the HF group. In the group of patients with HF and normal PASP, however, abnormalities of RV diastolic function were still common. It would appear, therefore, that there is a separate mechanism independent of PASP. Our study does not show precisely what this may be. However, we were unable to demonstrate any significant difference between patients with idiopathic dilated cardiomyopathy (who may have impaired RV function as part of the disease process) and patients with HF caused by large anterior myocardial infarctions in whom RV systolic function is normally preserved,17 although RV disease with myocyte loss and collagen accumulation is found in those patients with severe three-vessel disease and ischemic cardiomyopathy.18 Thus, it would appear that there may be other factors involved apart from the absence or presence of RV disease. It is clear that the anatomic and functional integrity of each ventricle is important determinant of the functional characteristics of the other ventricle.6 Although the effects of PHT and RV dilation on LV function have been studied,19 less attention has been paid to the effect of LV diastolic dysfunction on the right ventricle. An increased distention of either ventricle during diastole has been shown to alter the compliance and geometry of the opposite ventricle by either a direct mechanical effect (displacement of the septum) or some other indirect process.20 21 22 The right and left ventricles share common muscle bundles, septum, and pericardium.23 24 The mechanisms of ventricular interaction are unknown but may relate to restriction of ventricular filling by the pericardium,25 although most work has assessed only the effect of RV volume expansion on LV function26 rather than vice versa. Furthermore, the influence of volume changes in one ventricle on the filling dynamics of the other has not been studied. We found some correlation between individual RV diastolic parameters with those of the LV, suggesting that disordered mechanics of filling in one ventricle can directly affect the other, but this is unlikely to be the entire explanation.
In summary, we have demonstrated that RV diastolic dysfunction is a common feature in patients with HF and PHT with normal LV function. Second, we have shown that patients with HF with normal PASPs also have impaired RV diastolic dysfunction. This may be due in part to the disease process, such as in patients with dilated or ischemic cardiomyopathy, but also may be caused indirectly by coexistent LV diastolic dysfunction resulting from ventricular interdependence. It is possible that RV diastolic dysfunction may be equally important in determining symptoms and prognosis. Follow-up of this group of patients will help to answer this question.
| Selected Abbreviations and Acronyms |
|---|
|
Received September 18, 1995; revision received November 2, 1995; accepted November 5, 1995.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
F. Haddad, S. A. Hunt, D. N. Rosenthal, and D. J. Murphy Right Ventricular Function in Cardiovascular Disease, Part I: Anatomy, Physiology, Aging, and Functional Assessment of the Right Ventricle Circulation, March 18, 2008; 117(11): 1436 - 1448. [Full Text] [PDF] |
||||
![]() |
T. L Gentles Watching the right ventricle in treated congenital heart disease Heart, December 1, 2007; 93(12): 1502 - 1503. [Abstract] [Full Text] [PDF] |
||||
![]() |
H B Grotenhuis, L J M Kroft, S G C van Elderen, J J M Westenberg, J Doornbos, M G Hazekamp, H W Vliegen, J Ottenkamp, and A de Roos Right ventricular hypertrophy and diastolic dysfunction in arterial switch patients without pulmonary artery stenosis Heart, December 1, 2007; 93(12): 1604 - 1608. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Tallaj, J. K. Kirklin, R. N. Brown, B. K. Rayburn, R. C. Bourge, R. L. Benza, L. Pinderski, S. Pamboukian, D. C. McGiffin, and D. C. Naftel Post-Heart Transplant Diastolic Dysfunction Is a Risk Factor for Mortality J. Am. Coll. Cardiol., September 11, 2007; 50(11): 1064 - 1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cortina, J. Bermejo, R. Yotti, M. M. Desco, D. Rodriguez-Perez, J. C. Antoranz, J. L. Rojo-Alvarez, D. Garcia, M. A. Garcia-Fernandez, and F. Fernandez-Aviles Noninvasive Assessment of the Right Ventricular Filling Pressure Gradient Circulation, August 28, 2007; 116(9): 1015 - 1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T.-J. Gan, S. Holverda, J. T. Marcus, W. J. Paulus, K. M. Marques, J. G.F. Bronzwaer, J. W. Twisk, A. Boonstra, P. E. Postmus, and A. Vonk-Noordegraaf Right Ventricular Diastolic Dysfunction and the Acute Effects of Sildenafil in Pulmonary Hypertension Patients Chest, July 1, 2007; 132(1): 11 - 17. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lichodziejewska, K. Kurnicka, K. Grudzka, J. Malysz, M. Ciurzynski, and D. Liszewska-Pfejfer Chronic and Acute Effects of Smoking on Left and Right Ventricular Relaxation in Young Healthy Smokers Chest, April 1, 2007; 131(4): 1142 - 1148. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D'Andrea, S. Stisi, S. Bellissimo, F. Vigorito, F. Scotto di Uccio, N. Tozzi, F. Moscato, E. Pezzullo, R. Calabro, and M. Scherillo Early impairment of myocardial function in systemic sclerosis: Non-invasive assessment by Doppler myocardial and strain rate imaging Eur J Echocardiogr, December 1, 2005; 6(6): 407 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Moyssakis, R Tzanetea, P Tsaftaridis, I Rombos, D P Papadopoulos, V Kalotychou, and A Aessopos Systolic and diastolic function in middle aged patients with sickle {beta} thalassaemia. An echocardiographic study Postgrad. Med. J., November 1, 2005; 81(961): 711 - 714. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Perrier, B.-G. Kerfant, N. Lalevee, P. Bideaux, M. F. Rossier, S. Richard, A. M. Gomez, and J.-P. Benitah Mineralocorticoid Receptor Antagonism Prevents the Electrical Remodeling That Precedes Cellular Hypertrophy After Myocardial Infarction Circulation, August 17, 2004; 110(7): 776 - 783. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-M. Yu, H. Lin, L. C. C. Kum, W.-F. Lam, W.-H. Fung, and J. E. Sanderson Evidence of atrial mechanical dysfunction by acoustic quantification in abnormal relaxation and restrictive filling patterns of diastolic dysfunction in patients with coronary artery disease Eur J Echocardiogr, December 1, 2003; 4(4): 272 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Drozdz, M. Krzeminska-Pakula, M. Plewka, M. Ciesielczyk, and J. D. Kasprzak Prognostic Value of Low-Dose Dobutamine Echocardiography in Patients With Idiopathic Dilated Cardiomyopathy* Chest, April 1, 2002; 121(4): 1216 - 1222. [Abstract] [Full Text] [PDF] |
||||
![]() |
C-M Yu, B M Y Cheung, R Leung, Q Wang, W-H Lai, and C-P Lau Increase in plasma adrenomedullin in patients with heart failure characterised by diastolic dysfunction Heart, August 1, 2001; 86(2): 155 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. M. Kroft, P. Simons, J. M. van Laar, and A. de Roos Patients with Pulmonary Fibrosis: Cardiac Function Assessed with MR Imaging Radiology, August 1, 2000; 216(2): 464 - 471. [Abstract] [Full Text] |
||||
![]() |
A. D. Wickenden, R. Kaprielian, X.-M. You, and P. H. Backx The thyroid hormone analog DITPA restores Ito in rats after myocardial infarction Am J Physiol Heart Circ Physiol, April 1, 2000; 278(4): H1105 - H1116. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. VIGNON, L. WEINERT, V. MOR-AVI, K. T. SPENCER, J. BEDNARZ, and R. M. LANG Quantitative Assessment of Regional Right Ventricular Function with Color Kinesis Am. J. Respir. Crit. Care Med., June 1, 1999; 159(6): 1949 - 1959. [Abstract] [Full Text] |
||||
![]() |
M. Y. Henein, C. A. O'Sullivan, A. J. S. Coats, and D. G. Gibson Angiotensin-converting enzyme (ACE) inhibitors revert abnormal right ventricular filling in patients with restrictive left ventricular disease J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1187 - 1193. [Abstract] [Full Text] [PDF] |
||||
![]() |
J E Sanderson, S K W Chan, C M Yu, L Y C Yeung, W M Chan, K Raymond, K W Chan, and K S Woo beta Blockers in heart failure: a comparison of a vasodilating beta blocker with metoprolol Heart, January 1, 1998; 79(1): 86 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. T. Weber Extracellular Matrix Remodeling in Heart Failure : A Role for De Novo Angiotensin II Generation Circulation, December 2, 1997; 96(11): 4065 - 4082. [Full Text] |
||||
![]() |
C.-M. Yu, H. Lin, H. Yang, S.-L. Kong, Q. Zhang, and S. W.-L. Lee Progression of Systolic Abnormalities in Patients With "Isolated" Diastolic Heart Failure and Diastolic Dysfunction Circulation, March 12, 2002; 105(10): 1195 - 1201. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |